{"uri":"laboratory-protocols-for-the-study-whole-genome-an-h4vb8w6","version_id":"0","protocol_name":"Laboratory protocols for the study  \u201cWhole genome analysis of selected human and animal rotaviruses identified in Uganda from 2012 to 2014 reveals complex genome re-assortment events between human, bovine, caprine and porcine strains\u201d.","protocol_name_html":"Laboratory protocols for the study  \u201cWhole genome analysis of selected human and animal rotaviruses identified in Uganda from 2012 to 2014 reveals complex genome re-assortment events between human, bovine, caprine and porcine strains\u201d.","is_prepublished":"0","can_edit":"0","parent_id":null,"api_version":"1","is_new_mode":"1","last_modified":"1521784801","type_id":"1","link":"https:\/\/doi.org\/10.1371\/journal.pone.0178855","fork_id":"","public_fork_note":null,"number_of_steps":"8","has_versions":"0","first_published_date":"1498673227","publish_date":"2017-06-28 18:07:07","documents":null,"have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"-45","mod_secs":"1","description":"","is_bookmarked":"0","can_reassign":"1","before_start":"","has_guidelines":"0","materials":[],"warning":"","version_class":"6005","public":"1","is_owner":"1","is_original_owner":"1","created_on":"1495203984","protocol_affiliation":"1 EPI laboratory, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda  2Department of Paediatrics and Child Health, College of Health Sciences,    Makerere University, P.O. BOX 7072, Kampala Uganda 3 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 4 Malawi-Liverpool-Wellcome Trust Clinical Research Programme \/ Department of Medical Laboratory Sciences, University of Malawi, College of Medicine, Blantyre, Malawi 5 Department of Microbiology, College of Veterinary Medicine and Biosecurity, Makerere University, P.O.BOX 7072, Kampala, Uganda   6Department of Biology and Kinesiology,  LeTourneau University, Longview, Texas, USA 7Department of Medicine, University of Cambridge, Cambridge, UK  *Corresponding author: Josephine Bwogi, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda. Email: josephinebwn@yahoo.co.uk or jbwogi@uvri.go.ug","affiliation":null,"doi":"dx.doi.org\/10.17504\/protocols.io.h4vb8w6","doi_status":"2","changed_fork_steps":null,"profile_url":"x2z244w2v2","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","profile_image":"\/img\/avatars\/012.png","full_name":"Josephine  Bwogi","created_by":"Josephine  Bwogi","private_link":"27DABA8E5D1C2B464782C98D30248AB8","original_img":"1","username":"josephine-bwogi","is_retracted":"0","retraction_reason":null,"plos_id":"10.1371\/journal.pone.0178855","manuscript_citation":"Bwogi J,  Jere KC,  Karamagi C,  Byarugaba DK,  Namuwulya P,  Baliraine FN,  Desselberger U,  Iturriza-Gomara M (2017) Whole genome analysis of selected human and animal rotaviruses identified in Uganda from 2012 to 2014 reveals complex genome reassortment events between human, bovine, caprine and porcine strains. PLoS ONE  12(6): e0178855. doi: <a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1371\/journal.pone.0178855\">10.1371\/journal.pone.0178855<\/a> ","journal_name":"PLOS One","is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":246065,"fork_info":[],"compare_forks":[],"protocols":[],"groups":[],"number_of_shared_runs":[],"ownership_history":[],"keywords":"Species A rotavirus (RVA), Bovine RVA, Caprine RVA, Porcine RVA, Human RVA, Interspecies transmission, Anthroponotic transmission, Whole genome analysis","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"2","collections":[],"tags":[],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[{"badge_id":"2","badge_image":"\/img\/badges\/bronze.svg","badge_description":"Author!"},{"badge_id":"5","badge_image":"\/img\/badges\/earlyadopter.svg","badge_description":"Early adopter"}],"number_of_comments":0,"is_locked":0,"is_locked_by":false,"authors":"Josephine Bwogi1,2,  Khuzwayo  C. Jere3, 4 , Charles Karamagi2, Denis  K. Byarugaba5,  Prossy Namuwulya1, Frederick  N. Baliraine6 , Ulrich Desselberger7 , Miren Iturriza-Gomara3.","authors_list":[{"name":"Josephine Bwogi1","affiliation":"1 EPI laboratory, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda  2Department of Paediatrics and Child Health, College of Health Sciences,    Makerere University, P.O. BOX 7072, Kampala Uganda 3 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 4 Malawi-Liverpool-Wellcome Trust Clinical Research Programme \/ Department of Medical Laboratory Sciences, University of Malawi, College of Medicine, Blantyre, Malawi 5 Department of Microbiology, College of Veterinary Medicine and Biosecurity, Makerere University, P.O.BOX 7072, Kampala, Uganda   6Department of Biology and Kinesiology,  LeTourneau University, Longview, Texas, USA 7Department of Medicine, University of Cambridge, Cambridge, UK  *Corresponding author: Josephine Bwogi, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda. Email: josephinebwn@yahoo.co.uk or jbwogi@uvri.go.ug","username":null,"profile_image":null},{"name":"2","affiliation":"1 EPI laboratory, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda  2Department of Paediatrics and Child Health, College of Health Sciences,    Makerere University, P.O. BOX 7072, Kampala Uganda 3 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 4 Malawi-Liverpool-Wellcome Trust Clinical Research Programme \/ Department of Medical Laboratory Sciences, University of Malawi, College of Medicine, Blantyre, Malawi 5 Department of Microbiology, College of Veterinary Medicine and Biosecurity, Makerere University, P.O.BOX 7072, Kampala, Uganda   6Department of Biology and Kinesiology,  LeTourneau University, Longview, Texas, USA 7Department of Medicine, University of Cambridge, Cambridge, UK  *Corresponding author: Josephine Bwogi, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda. Email: josephinebwn@yahoo.co.uk or jbwogi@uvri.go.ug","username":null,"profile_image":null},{"name":"  Khuzwayo  C. Jere3","affiliation":"1 EPI laboratory, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda  2Department of Paediatrics and Child Health, College of Health Sciences,    Makerere University, P.O. BOX 7072, Kampala Uganda 3 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 4 Malawi-Liverpool-Wellcome Trust Clinical Research Programme \/ Department of Medical Laboratory Sciences, University of Malawi, College of Medicine, Blantyre, Malawi 5 Department of Microbiology, College of Veterinary Medicine and Biosecurity, Makerere University, P.O.BOX 7072, Kampala, Uganda   6Department of Biology and Kinesiology,  LeTourneau University, Longview, Texas, USA 7Department of Medicine, University of Cambridge, Cambridge, UK  *Corresponding author: Josephine Bwogi, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda. Email: josephinebwn@yahoo.co.uk or jbwogi@uvri.go.ug","username":null,"profile_image":null},{"name":" 4 ","affiliation":"1 EPI laboratory, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda  2Department of Paediatrics and Child Health, College of Health Sciences,    Makerere University, P.O. BOX 7072, Kampala Uganda 3 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 4 Malawi-Liverpool-Wellcome Trust Clinical Research Programme \/ Department of Medical Laboratory Sciences, University of Malawi, College of Medicine, Blantyre, Malawi 5 Department of Microbiology, College of Veterinary Medicine and Biosecurity, Makerere University, P.O.BOX 7072, Kampala, Uganda   6Department of Biology and Kinesiology,  LeTourneau University, Longview, Texas, USA 7Department of Medicine, University of Cambridge, Cambridge, UK  *Corresponding author: Josephine Bwogi, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda. Email: josephinebwn@yahoo.co.uk or jbwogi@uvri.go.ug","username":null,"profile_image":null},{"name":" Charles Karamagi2","affiliation":"1 EPI laboratory, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda  2Department of Paediatrics and Child Health, College of Health Sciences,    Makerere University, P.O. BOX 7072, Kampala Uganda 3 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 4 Malawi-Liverpool-Wellcome Trust Clinical Research Programme \/ Department of Medical Laboratory Sciences, University of Malawi, College of Medicine, Blantyre, Malawi 5 Department of Microbiology, College of Veterinary Medicine and Biosecurity, Makerere University, P.O.BOX 7072, Kampala, Uganda   6Department of Biology and Kinesiology,  LeTourneau University, Longview, Texas, USA 7Department of Medicine, University of Cambridge, Cambridge, UK  *Corresponding author: Josephine Bwogi, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda. Email: josephinebwn@yahoo.co.uk or jbwogi@uvri.go.ug","username":null,"profile_image":null},{"name":" Denis  K. Byarugaba5","affiliation":"1 EPI laboratory, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda  2Department of Paediatrics and Child Health, College of Health Sciences,    Makerere University, P.O. BOX 7072, Kampala Uganda 3 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 4 Malawi-Liverpool-Wellcome Trust Clinical Research Programme \/ Department of Medical Laboratory Sciences, University of Malawi, College of Medicine, Blantyre, Malawi 5 Department of Microbiology, College of Veterinary Medicine and Biosecurity, Makerere University, P.O.BOX 7072, Kampala, Uganda   6Department of Biology and Kinesiology,  LeTourneau University, Longview, Texas, USA 7Department of Medicine, University of Cambridge, Cambridge, UK  *Corresponding author: Josephine Bwogi, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda. Email: josephinebwn@yahoo.co.uk or jbwogi@uvri.go.ug","username":null,"profile_image":null},{"name":"  Prossy Namuwulya1","affiliation":"1 EPI laboratory, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda  2Department of Paediatrics and Child Health, College of Health Sciences,    Makerere University, P.O. BOX 7072, Kampala Uganda 3 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 4 Malawi-Liverpool-Wellcome Trust Clinical Research Programme \/ Department of Medical Laboratory Sciences, University of Malawi, College of Medicine, Blantyre, Malawi 5 Department of Microbiology, College of Veterinary Medicine and Biosecurity, Makerere University, P.O.BOX 7072, Kampala, Uganda   6Department of Biology and Kinesiology,  LeTourneau University, Longview, Texas, USA 7Department of Medicine, University of Cambridge, Cambridge, UK  *Corresponding author: Josephine Bwogi, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda. Email: josephinebwn@yahoo.co.uk or jbwogi@uvri.go.ug","username":null,"profile_image":null},{"name":" Frederick  N. Baliraine6 ","affiliation":"1 EPI laboratory, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda  2Department of Paediatrics and Child Health, College of Health Sciences,    Makerere University, P.O. BOX 7072, Kampala Uganda 3 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 4 Malawi-Liverpool-Wellcome Trust Clinical Research Programme \/ Department of Medical Laboratory Sciences, University of Malawi, College of Medicine, Blantyre, Malawi 5 Department of Microbiology, College of Veterinary Medicine and Biosecurity, Makerere University, P.O.BOX 7072, Kampala, Uganda   6Department of Biology and Kinesiology,  LeTourneau University, Longview, Texas, USA 7Department of Medicine, University of Cambridge, Cambridge, UK  *Corresponding author: Josephine Bwogi, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda. Email: josephinebwn@yahoo.co.uk or jbwogi@uvri.go.ug","username":null,"profile_image":null},{"name":" Ulrich Desselberger7 ","affiliation":"1 EPI laboratory, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda  2Department of Paediatrics and Child Health, College of Health Sciences,    Makerere University, P.O. BOX 7072, Kampala Uganda 3 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 4 Malawi-Liverpool-Wellcome Trust Clinical Research Programme \/ Department of Medical Laboratory Sciences, University of Malawi, College of Medicine, Blantyre, Malawi 5 Department of Microbiology, College of Veterinary Medicine and Biosecurity, Makerere University, P.O.BOX 7072, Kampala, Uganda   6Department of Biology and Kinesiology,  LeTourneau University, Longview, Texas, USA 7Department of Medicine, University of Cambridge, Cambridge, UK  *Corresponding author: Josephine Bwogi, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda. Email: josephinebwn@yahoo.co.uk or jbwogi@uvri.go.ug","username":null,"profile_image":null},{"name":" Miren Iturriza-Gomara3.","affiliation":"1 EPI laboratory, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda  2Department of Paediatrics and Child Health, College of Health Sciences,    Makerere University, P.O. BOX 7072, Kampala Uganda 3 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 4 Malawi-Liverpool-Wellcome Trust Clinical Research Programme \/ Department of Medical Laboratory Sciences, University of Malawi, College of Medicine, Blantyre, Malawi 5 Department of Microbiology, College of Veterinary Medicine and Biosecurity, Makerere University, P.O.BOX 7072, Kampala, Uganda   6Department of Biology and Kinesiology,  LeTourneau University, Longview, Texas, USA 7Department of Medicine, University of Cambridge, Cambridge, UK  *Corresponding author: Josephine Bwogi, Uganda Virus Research Institute, 51-59 Nakiwogo Road, P.0.BOX 49, Entebbe, Uganda. Email: josephinebwn@yahoo.co.uk or jbwogi@uvri.go.ug","username":null,"profile_image":null}],"user":{"profile_image":"\/img\/avatars\/012.png","username":"josephine-bwogi","full_name":"Josephine  Bwogi","created_by":"Josephine  Bwogi"},"access":{"can_view":"1","can_remove":"0","can_add":"0","can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":"0","can_move":"1","can_transfer":"1","can_download":"1","is_locked":"0"},"is_contact_suspended":0,"guidelines":"","status_id":"1","is_research":"1","status_info":null,"steps":[{"id":"509262","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"62AA6DF7C5E04EAA972B7EC842FED85C","previous_guid":null,"previous_id":"0","last_modified":"1495204055","components":[{"component_id":"826981","previous_id":0,"original_id":"0","guid":"7B2B0FE781BC47D2B2E463BDF8CE64D4","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<p>Human stool suspension(approximately 100 mg of stool) were suspended in 200 \u00b5l of Phosphate Buffered Saline Solution (PBS) or 200 \u00b5l of semi-formed stool was mixed with 150 \u00b5l of PBS.<\/p>\n<p>\u00a0<\/p>\n<p>Animal Feacal suspensions of 10-20% were prepared in PBS in 2 ml nunc tubes by adding 200ul of liquid sample or a bacteriological loop full (the size of a garden pea) from semi-solid samples to 2 ml of PBS. The 10% suspensions were stored at -70<sup> o<\/sup>C.<\/p>\n<p>\u00a0<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Human stool suspension(approximately 100 mg of stool) were suspended in 200 \u00b5l of Phosphate Buffered Saline Solution (PBS) or 200 \u00b5l of semi-formed stool was mixed with 150 \u00b5l of PBS.<\/p>\n<p>\u00a0<\/p>\n<p>Animal Feacal suspensions of 10-20% were prepared in PBS in 2 ml nunc tubes by adding 200ul of liquid sample or a bacteriological loop full (the size of a garden pea) from semi-solid samples to 2 ml of PBS. The 10% suspensions were stored at -70<sup> o<\/sup>C.<\/p>\n<p>\u00a0<\/p>"},"is_project":0},{"component_id":"826970","previous_id":"826981","original_id":"0","guid":"BD579D4B302C4A87A0D0A57C5219F0E1","previous_guid":"7B2B0FE781BC47D2B2E463BDF8CE64D4","component_type_id":"6","data_id":"0","data":"Preparation of feacal suspension","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Preparation of feacal suspension"},"is_project":0}]},{"id":"509266","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"510CEBDFF9094EA9AB6E4C7757935EAA","previous_guid":"62AA6DF7C5E04EAA972B7EC842FED85C","previous_id":"509262","last_modified":"1495204127","components":[{"component_id":"826984","previous_id":0,"original_id":"0","guid":"1B51F480191D4A6E83C2A101EFB1F269","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<p>RNA was extracted using the guanidinium isothiocyanate (GTC)\/ silica gel extraction of nucleic acid (The 'Boom' method) [1]. Two hundred (200) ul of faecal suspension prepared as above, was added to 1ml of lysis buffer-L6 buffer (annex) and 20ul of size fractionated silica (annex) in a 1.5ml screw-capped microcentrifuge tube. RNase-free distilled water was included in each run to act as a negative control. The mixture was vortexed for 10 seconds and incubated at room temperature for 15 minutes. Centrifugation for 15 seconds at 18000 g was then done. The supernatant was discarded as toxic waste and the pellet kept for the next step. The pellet was then washed with 1 ml of lysis buffer L2 (annex) by vortexing, then pelleted by centrifugation at 18000 g. The wash with L2 Buffer was repeated once. The wash was then done twice with 1ml 70% ethanol and 1ml acetone once. After removal of the acetone (performed carefully to avoid pellet dislodging), centrifugation was done at 18000 g. The tubes were then placed with lid open at 56<sup>o<\/sup>C in a dry heating block for 5 minutes. Forty (40) ul of RNase free water were added to the pellet, vortexed and incubated at 56<sup>o<\/sup>C for 15 minutes to elute the nucleic acid from the silica. The pellet was centrifuged at 180000 g for 4 min and the supernatant was extracted (avoid disturbing the silica). This was then stored in a new microfuge tube at 4<sup>o<\/sup>C for 24h or at -70<sup>o<\/sup>C for longer.<\/p>\n<p>\u00a0<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>RNA was extracted using the guanidinium isothiocyanate (GTC)\/ silica gel extraction of nucleic acid (The 'Boom' method) [1]. Two hundred (200) ul of faecal suspension prepared as above, was added to 1ml of lysis buffer-L6 buffer (annex) and 20ul of size fractionated silica (annex) in a 1.5ml screw-capped microcentrifuge tube. RNase-free distilled water was included in each run to act as a negative control. The mixture was vortexed for 10 seconds and incubated at room temperature for 15 minutes. Centrifugation for 15 seconds at 18000 g was then done. The supernatant was discarded as toxic waste and the pellet kept for the next step. The pellet was then washed with 1 ml of lysis buffer L2 (annex) by vortexing, then pelleted by centrifugation at 18000 g. The wash with L2 Buffer was repeated once. The wash was then done twice with 1ml 70% ethanol and 1ml acetone once. After removal of the acetone (performed carefully to avoid pellet dislodging), centrifugation was done at 18000 g. The tubes were then placed with lid open at 56<sup>o<\/sup>C in a dry heating block for 5 minutes. Forty (40) ul of RNase free water were added to the pellet, vortexed and incubated at 56<sup>o<\/sup>C for 15 minutes to elute the nucleic acid from the silica. The pellet was centrifuged at 180000 g for 4 min and the supernatant was extracted (avoid disturbing the silica). This was then stored in a new microfuge tube at 4<sup>o<\/sup>C for 24h or at -70<sup>o<\/sup>C for longer.<\/p>\n<p>\u00a0<\/p>"},"is_project":0},{"component_id":"826983","previous_id":"826984","original_id":"0","guid":"74192E75575D4CDEB35D38D21443DBB7","previous_guid":"1B51F480191D4A6E83C2A101EFB1F269","component_type_id":"6","data_id":"0","data":"RNA extraction using the guanidinium isothiocyanate","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"RNA extraction using the guanidinium isothiocyanate"},"is_project":0}]},{"id":"509269","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"F26D7103B51A41779A477903D160A465","previous_guid":"510CEBDFF9094EA9AB6E4C7757935EAA","previous_id":"509266","last_modified":"1495204172","components":[{"component_id":"826987","previous_id":0,"original_id":"0","guid":"A148F72A4FE24B5999F59464F6902491","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<p>Human RV RNA was extracted using TRIZOL LS Reagent (Invitrogen). Approximately 100 mg of stool were suspended in 200ul of PBS or 200ul of semi-formed stool was mixed with 150ul of PBS. One ml of TRIZOL was added, vortex and let to stand for 5 minutes. Then 270ul of chloroform was added, the mixture was vortexed and let to stand for 3 minutes. The mixture was then centrifuged at 4<sup>o<\/sup>C for 20 minutes at 18000 g. One ml of ice-cold isopropanol was put in sterile tubes, in which the supernatant from the mixture was added, mixed by inversion and samples were let to stand for 5 minutes at room temperature. The RNA was precipitated by centrifugation of the mixture at room temperature for 30 minutes at 18000 g . The supernatant was discarded, and the pellet was dried by air for 10 minutes before suspending in 90ul of nuclease free water.<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Human RV RNA was extracted using TRIZOL LS Reagent (Invitrogen). Approximately 100 mg of stool were suspended in 200ul of PBS or 200ul of semi-formed stool was mixed with 150ul of PBS. One ml of TRIZOL was added, vortex and let to stand for 5 minutes. Then 270ul of chloroform was added, the mixture was vortexed and let to stand for 3 minutes. The mixture was then centrifuged at 4<sup>o<\/sup>C for 20 minutes at 18000 g. One ml of ice-cold isopropanol was put in sterile tubes, in which the supernatant from the mixture was added, mixed by inversion and samples were let to stand for 5 minutes at room temperature. The RNA was precipitated by centrifugation of the mixture at room temperature for 30 minutes at 18000 g . The supernatant was discarded, and the pellet was dried by air for 10 minutes before suspending in 90ul of nuclease free water.<\/p>"},"is_project":0},{"component_id":"826986","previous_id":"826987","original_id":"0","guid":"1F3D6A95116D40149E2F9207C56A3DF2","previous_guid":"A148F72A4FE24B5999F59464F6902491","component_type_id":"6","data_id":"0","data":"RNA Extraction using TRIZOL LS Reagent (Invitrogen)","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"RNA Extraction using TRIZOL LS Reagent (Invitrogen)"},"is_project":0}]},{"id":"509272","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"557FA9B1E5784C56986B80C6C7FD8863","previous_guid":"F26D7103B51A41779A477903D160A465","previous_id":"509269","last_modified":"1495204244","components":[{"component_id":"826990","previous_id":0,"original_id":"0","guid":"9E8A146A74814BA5A7CD8E8E3A3FC537","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<p>cDNA synthesis, PCR amplification and purification of the entire rotavirus genome were carried out on the human samples that yielded more than 2 ng\/\u00b5l dsRNA as described previously [2, 3]. This is detailed below:<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>RNA purification<\/p>\n<p>30 ul of 8M Lithuim chloride was added to 90 ul of the double-stranded rotavirus RNA (dsRNA) extracted from each human and animal sample to remove single stranded RNAs. This was then incubated at 4<sup>o<\/sup>C overnight (16 hours). Samples were then spun for 30 minutes at 18000 g. The extracted dsRNA was then purified using a Min ELUTE gel extraction kit (Qiagen) following the manufacturer\u2019s instructions. The dsRNA was assessed using 1% Tris-borate Ethylenediaminetetracetic acid (TBE) agarose gel stained with ethidium bromide.<\/p>\n<p>\u00a0<\/p>\n<p>Oligoligation<\/p>\n<p>The double stranded RNA was oligoligated using PC3-T7 (5\u2019-p-GGATCCCGGGAATTCGGTAATACGACTCACTATATATTTTTATAGTGAGTCGTATTA-OH-3\u2019) loop primer and PC2 (5\u2019-p-CCGAATTCCCGGGATCC-3\u2019) primer as previously described [2] . In detail: The PC3-T7 loop (200ng) was ligated to dsRNA (0.4-200ng) in 50nM HEPES (NaoH, pH 8.0 (Sigma), 18nM MgCl<sub>2<\/sub> (Separations), 0.01% BSA (TaKaRa), 1mM ATP\u00a0\u00a0 (Roche), 3 mM Dithiothrectal (DTT)(Roche), 10% DMSO (Sigma), 20% polyethyleneglycol (PEG)<sub>6000<\/sub> (BDH) and 30 U T4 RNA ligase (TaKaRa) in a final volume of 30ul. This was then incubated at 37<sup>o<\/sup>C for 16 hours for ligation to take place.<\/p>\n<p>The ligated dsRNA was purified using the MinElute Gel extraction kit (Qiagen) following the manufacturer\u2019s instructions.<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>cDNA synthesis and PCR amplification of the rotavirus genome<\/p>\n<p>The purified dsRNA (7ul) was denatured using 1ul of 300mM methylmercury hydroxide (Alfa Aesar). This was left to stand for 10-30 minutes at room temperature.<\/p>\n<p>Reverse transcription of the dsRNA to synthesize cDNA: The reaction contained 50Mm Tris\/HCl, pH 8.3 (Sigma), 10 mM MgCl<sub>2<\/sub> (Separations), 70Mm KCl(Sigma), 30 Mm \u03b2-mercaptolethanol(Sigma), 1 mMdNTPs(TaKaRa) and 15 U cloned AMV reverse transcriptase (Invitrogen). The reaction was incubated in a thermal cyckler at 42<sup>o<\/sup>C for 45 minutes followed by 55<sup> o<\/sup>C for 15 minutes, and held at 10<sup> o<\/sup>C.<\/p>\n<p>The tubes were removed from the thermocycycler, vortexed and spun briefly. Then 3ul of Sodium hydroxide (Sigma) was added to end with 0.1M (aimed at removing the excess RNA. Then incubated at 65<sup> o<\/sup>C for 20-30 minutes.<\/p>\n<p>Six (6 ul) Tris\/HCl 50nM, pH8.3 (Sigma) was then added to the mixture and incubated 65 <sup>o<\/sup>C for one hour (annealing of cDNA) .<\/p>\n<p>\u00a0\u00a0 cDNA was then amplified using primer PC2 under the following reaction conditions: one cycle at 72 <sup>o<\/sup>C for 2 minutes, followed by 25 cycles each of 94 <sup>o<\/sup>C for 2 minutes, 65 <sup>o<\/sup>C for 30 seconds and 72 <sup>o<\/sup>C for 4 minutes. This was followed by an extension step at 72 <sup>o<\/sup>C for 5 minutes. The PCR mixture contained 31ul of deionised water, 5ul of extracted Taq buffer, 4ul of dNTPs (10Mm\/ul) 0.5ul primer (PC2), 4 ul MgCl<sub>2<\/sub> and 0.5 ul Taq enzyme (TaKaRa). Forty five (45)ul of PCR mixiture was added to 5 ul cDNA .<\/p>\n<p>The amplified cDNA (2ul) was evaluated on a 1% TBE agarose gel stained with ethidium bromide.<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>cDNA synthesis, PCR amplification and purification of the entire rotavirus genome were carried out on the human samples that yielded more than 2 ng\/\u00b5l dsRNA as described previously [2, 3]. This is detailed below:<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>RNA purification<\/p>\n<p>30 ul of 8M Lithuim chloride was added to 90 ul of the double-stranded rotavirus RNA (dsRNA) extracted from each human and animal sample to remove single stranded RNAs. This was then incubated at 4<sup>o<\/sup>C overnight (16 hours). Samples were then spun for 30 minutes at 18000 g. The extracted dsRNA was then purified using a Min ELUTE gel extraction kit (Qiagen) following the manufacturer\u2019s instructions. The dsRNA was assessed using 1% Tris-borate Ethylenediaminetetracetic acid (TBE) agarose gel stained with ethidium bromide.<\/p>\n<p>\u00a0<\/p>\n<p>Oligoligation<\/p>\n<p>The double stranded RNA was oligoligated using PC3-T7 (5\u2019-p-GGATCCCGGGAATTCGGTAATACGACTCACTATATATTTTTATAGTGAGTCGTATTA-OH-3\u2019) loop primer and PC2 (5\u2019-p-CCGAATTCCCGGGATCC-3\u2019) primer as previously described [2] . In detail: The PC3-T7 loop (200ng) was ligated to dsRNA (0.4-200ng) in 50nM HEPES (NaoH, pH 8.0 (Sigma), 18nM MgCl<sub>2<\/sub> (Separations), 0.01% BSA (TaKaRa), 1mM ATP\u00a0\u00a0 (Roche), 3 mM Dithiothrectal (DTT)(Roche), 10% DMSO (Sigma), 20% polyethyleneglycol (PEG)<sub>6000<\/sub> (BDH) and 30 U T4 RNA ligase (TaKaRa) in a final volume of 30ul. This was then incubated at 37<sup>o<\/sup>C for 16 hours for ligation to take place.<\/p>\n<p>The ligated dsRNA was purified using the MinElute Gel extraction kit (Qiagen) following the manufacturer\u2019s instructions.<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>cDNA synthesis and PCR amplification of the rotavirus genome<\/p>\n<p>The purified dsRNA (7ul) was denatured using 1ul of 300mM methylmercury hydroxide (Alfa Aesar). This was left to stand for 10-30 minutes at room temperature.<\/p>\n<p>Reverse transcription of the dsRNA to synthesize cDNA: The reaction contained 50Mm Tris\/HCl, pH 8.3 (Sigma), 10 mM MgCl<sub>2<\/sub> (Separations), 70Mm KCl(Sigma), 30 Mm \u03b2-mercaptolethanol(Sigma), 1 mMdNTPs(TaKaRa) and 15 U cloned AMV reverse transcriptase (Invitrogen). The reaction was incubated in a thermal cyckler at 42<sup>o<\/sup>C for 45 minutes followed by 55<sup> o<\/sup>C for 15 minutes, and held at 10<sup> o<\/sup>C.<\/p>\n<p>The tubes were removed from the thermocycycler, vortexed and spun briefly. Then 3ul of Sodium hydroxide (Sigma) was added to end with 0.1M (aimed at removing the excess RNA. Then incubated at 65<sup> o<\/sup>C for 20-30 minutes.<\/p>\n<p>Six (6 ul) Tris\/HCl 50nM, pH8.3 (Sigma) was then added to the mixture and incubated 65 <sup>o<\/sup>C for one hour (annealing of cDNA) .<\/p>\n<p>\u00a0\u00a0 cDNA was then amplified using primer PC2 under the following reaction conditions: one cycle at 72 <sup>o<\/sup>C for 2 minutes, followed by 25 cycles each of 94 <sup>o<\/sup>C for 2 minutes, 65 <sup>o<\/sup>C for 30 seconds and 72 <sup>o<\/sup>C for 4 minutes. This was followed by an extension step at 72 <sup>o<\/sup>C for 5 minutes. The PCR mixture contained 31ul of deionised water, 5ul of extracted Taq buffer, 4ul of dNTPs (10Mm\/ul) 0.5ul primer (PC2), 4 ul MgCl<sub>2<\/sub> and 0.5 ul Taq enzyme (TaKaRa). Forty five (45)ul of PCR mixiture was added to 5 ul cDNA .<\/p>\n<p>The amplified cDNA (2ul) was evaluated on a 1% TBE agarose gel stained with ethidium bromide.<\/p>"},"is_project":0},{"component_id":"826989","previous_id":"826990","original_id":"0","guid":"4436713E6C6246BDA203BA48FCE94F0B","previous_guid":"9E8A146A74814BA5A7CD8E8E3A3FC537","component_type_id":"6","data_id":"0","data":"cDNA synthesis and PCR amplification of the entire rotavirus genome","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"cDNA synthesis and PCR amplification of the entire rotavirus genome"},"is_project":0}]},{"id":"509275","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"BD10C9C2E52146A8A75A196C99C0A232","previous_guid":"557FA9B1E5784C56986B80C6C7FD8863","previous_id":"509272","last_modified":"1495204285","components":[{"component_id":"827004","previous_id":0,"original_id":"0","guid":"8D8A84956F504138BB813DA591D6E2C4","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<p>The purified rotavirus cDNA PCR amplicons were subjected to standard bar-coding and library construction for Illumina sequencing using the Nextera XT DNA Library Preparation Kit by following the manufacturer\u2019s recommendations (Illumina Inc., CA, USA).<\/p>\n<p>\u00a0<\/p>\n<p>For all animal samples and human samples that yielded less than 2 ng\/\u00b5l dsRNA, the ScriptSeq v2 RNA-Seq Library Preparation Kit (Epicentre, Chicago, IL, USA) was used, following the manufacture\u2019s instructions with the slight modification of an initial denaturation step (95 \u00baC for 5 min). When the concentration of RNA input was less than 50ng\/\u00b5l, PCR cycles were increased up to 22 to obtain sufficient product for sequencing. Each library was indexed with Illumina compatible barcodes to allow multiplexing.<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>The purified rotavirus cDNA PCR amplicons were subjected to standard bar-coding and library construction for Illumina sequencing using the Nextera XT DNA Library Preparation Kit by following the manufacturer\u2019s recommendations (Illumina Inc., CA, USA).<\/p>\n<p>\u00a0<\/p>\n<p>For all animal samples and human samples that yielded less than 2 ng\/\u00b5l dsRNA, the ScriptSeq v2 RNA-Seq Library Preparation Kit (Epicentre, Chicago, IL, USA) was used, following the manufacture\u2019s instructions with the slight modification of an initial denaturation step (95 \u00baC for 5 min). When the concentration of RNA input was less than 50ng\/\u00b5l, PCR cycles were increased up to 22 to obtain sufficient product for sequencing. Each library was indexed with Illumina compatible barcodes to allow multiplexing.<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>"},"is_project":0},{"component_id":"826992","previous_id":"827004","original_id":"0","guid":"0337F960B68B42D5A326697EC3C40208","previous_guid":"8D8A84956F504138BB813DA591D6E2C4","component_type_id":"6","data_id":"0","data":"Library preparation","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Library preparation"},"is_project":0}]},{"id":"509279","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"26316904CC82498D97AA29FD97F4B149","previous_guid":"BD10C9C2E52146A8A75A196C99C0A232","previous_id":"509275","last_modified":"1495204324","components":[{"component_id":"827007","previous_id":0,"original_id":"0","guid":"A56CCE38A8F44FFB8A6AE35759FE9F04","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<ol>\n<li>NB. For this study we used commercial made L2 buffer, L6 buffer and size fractionated silica purchased from Severn Biotech Ltd, Unit 2 , Park lane, Kinderminiter, Worchestershire,UK)<\/li>\n<\/ol>\n<p>However, L2 buffer, L6 buffer and size fractionated silica can also be reconstituted in the lab as below [4]:<\/p>\n<p>\u00a0<\/p>\n<p>L6 Buffer<\/p>\n<p>Guanidium isothiocyanate (GTC)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 60gm<\/p>\n<p>0.1M Tris-HCL Ph 6.4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 50ml<\/p>\n<p>0.2M EDTA p H 8.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 11ml<\/p>\n<p>Triton X-100\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1.3gm<\/p>\n<p>\u00a0<\/p>\n<p>L2 Buffer<\/p>\n<p>GTC\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 180gm<\/p>\n<p>0.1M Tris-HCl pH 6.4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 150ml<\/p>\n<p>\u00a0<\/p>\n<p>Preparation of size fractioned silica<\/p>\n<p>Add Sixty (60) gm of silicon dioxide, SiO<sub>2<\/sub> (Sigma; S-5631) to demineralized water to a total volume of 500 ml in a measuring glass cylinder. Allow the silica to sediment under gravity for 24 hours at room temperature. Extract 430 ml of supernant and add demineralized water to 500 ml and shake vigorously. Sedimentfor 24 hours at room temperature. Extract 440 ml of supernant and add 600ul HCl (32%, w\/v) to adjust the silica suspension to pH 2.0.<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<ol>\n<li>NB. For this study we used commercial made L2 buffer, L6 buffer and size fractionated silica purchased from Severn Biotech Ltd, Unit 2 , Park lane, Kinderminiter, Worchestershire,UK)<\/li>\n<\/ol>\n<p>However, L2 buffer, L6 buffer and size fractionated silica can also be reconstituted in the lab as below [4]:<\/p>\n<p>\u00a0<\/p>\n<p>L6 Buffer<\/p>\n<p>Guanidium isothiocyanate (GTC)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 60gm<\/p>\n<p>0.1M Tris-HCL Ph 6.4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 50ml<\/p>\n<p>0.2M EDTA p H 8.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 11ml<\/p>\n<p>Triton X-100\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1.3gm<\/p>\n<p>\u00a0<\/p>\n<p>L2 Buffer<\/p>\n<p>GTC\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 180gm<\/p>\n<p>0.1M Tris-HCl pH 6.4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 150ml<\/p>\n<p>\u00a0<\/p>\n<p>Preparation of size fractioned silica<\/p>\n<p>Add Sixty (60) gm of silicon dioxide, SiO<sub>2<\/sub> (Sigma; S-5631) to demineralized water to a total volume of 500 ml in a measuring glass cylinder. Allow the silica to sediment under gravity for 24 hours at room temperature. Extract 430 ml of supernant and add demineralized water to 500 ml and shake vigorously. Sedimentfor 24 hours at room temperature. Extract 440 ml of supernant and add 600ul HCl (32%, w\/v) to adjust the silica suspension to pH 2.0.<\/p>"},"is_project":0},{"component_id":"827006","previous_id":"827007","original_id":"0","guid":"A8BF4270BD1E488BA2AC54629BF54DE5","previous_guid":"A56CCE38A8F44FFB8A6AE35759FE9F04","component_type_id":"6","data_id":"0","data":"ANNEX","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"ANNEX"},"is_project":0}]},{"id":"509282","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"B7F039E4A19A4A40B0B18FC70FA49A46","previous_guid":"26316904CC82498D97AA29FD97F4B149","previous_id":"509279","last_modified":"1495204381","components":[{"component_id":"827011","previous_id":0,"original_id":"0","guid":"82F026E961CE4C2B8B919F9542A2B99A","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<ol>\n<li>Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. Journal of clinical microbiology. 1990;28(3):495-503. Epub 1990\/03\/01. PubMed PMID: 1691208; PubMed Central PMCID: PMCPmc269651.<\/li>\n<\/ol>\n<p>\u00a0<\/p>\n<ol start=\"2\">\n<li>Potgieter AC, Page NA, Liebenberg J, Wright IM, Landt O, van Dijk AA. Improved strategies for sequence-independent amplification and sequencing of viral double-stranded RNA genomes. The Journal of general virology. 2009;90(Pt 6):1423-32. Epub 2009\/03\/07. doi: 10.1099\/vir.0.009381-0. PubMed PMID: 19264638.<\/li>\n<\/ol>\n<p>\u00a0<\/p>\n<ol start=\"3\">\n<li>Jere KC, Mlera L, O'Neill HG, Potgieter AC, Page NA, Seheri ML, et al. Whole genome analyses of African G2, G8, G9, and G12 rotavirus strains using sequence-independent amplification and 454(R) pyrosequencing. Journal of medical virology. 2011;83(11):2018-42. Epub 2011\/09\/15. doi: 10.1002\/jmv.22207. PubMed PMID: 21915879.<\/li>\n<\/ol>\n<p>\u00a0<\/p>\n<ol start=\"4\">\n<li>Rotavirus Detection and Typing. Eurorotanet. Version 4 ed2009.<\/li>\n<\/ol>\n<p>\u00a0<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<ol>\n<li>Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. Journal of clinical microbiology. 1990;28(3):495-503. Epub 1990\/03\/01. PubMed PMID: 1691208; PubMed Central PMCID: PMCPmc269651.<\/li>\n<\/ol>\n<p>\u00a0<\/p>\n<ol start=\"2\">\n<li>Potgieter AC, Page NA, Liebenberg J, Wright IM, Landt O, van Dijk AA. Improved strategies for sequence-independent amplification and sequencing of viral double-stranded RNA genomes. The Journal of general virology. 2009;90(Pt 6):1423-32. Epub 2009\/03\/07. doi: 10.1099\/vir.0.009381-0. PubMed PMID: 19264638.<\/li>\n<\/ol>\n<p>\u00a0<\/p>\n<ol start=\"3\">\n<li>Jere KC, Mlera L, O'Neill HG, Potgieter AC, Page NA, Seheri ML, et al. Whole genome analyses of African G2, G8, G9, and G12 rotavirus strains using sequence-independent amplification and 454(R) pyrosequencing. Journal of medical virology. 2011;83(11):2018-42. Epub 2011\/09\/15. doi: 10.1002\/jmv.22207. PubMed PMID: 21915879.<\/li>\n<\/ol>\n<p>\u00a0<\/p>\n<ol start=\"4\">\n<li>Rotavirus Detection and Typing. Eurorotanet. Version 4 ed2009.<\/li>\n<\/ol>\n<p>\u00a0<\/p>"},"is_project":0},{"component_id":"827009","previous_id":"827011","original_id":"0","guid":"BEFF513F6DE94BE680A14C5CC1CEE0E4","previous_guid":"82F026E961CE4C2B8B919F9542A2B99A","component_type_id":"6","data_id":"0","data":"References","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"References"},"is_project":0}]},{"id":"509286","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"68EFD56C0AA5478498BE4925D1B22C95","previous_guid":"B7F039E4A19A4A40B0B18FC70FA49A46","previous_id":"509282","last_modified":"1495204435","components":[{"component_id":"1078078","previous_id":0,"original_id":"0","guid":"0004213DA70C4BDFB1BBF070612F99DB","previous_guid":null,"component_type_id":"6","data_id":"0","data":"","order_id":"0","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":""},"is_project":0},{"component_id":"1078403","previous_id":"1078078","original_id":"0","guid":"698078A5C9774DF294A20F62D0C83312","previous_guid":"0004213DA70C4BDFB1BBF070612F99DB","component_type_id":"1","data_id":"0","data":"","order_id":"1","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":""},"is_project":0}]}]}